new labeling about the possible cardiovascular risk related to Avandia and other diabetes meds

You'll see new labeling about the possible cardiovascular risk related to Avandia and other diabetes meds.

These will go beyond Avandia's and Actos's current black box warning about edema and heart failure.

The new warning will focus on whether Avandia increases the risk of ischemic events...angina and heart attacks.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote